Artykuły udostępnione publicznie: - Wooseong KimWięcej informacji
Niedostępne w żadnym miejscu: 2
An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs
W Kim, GL Hendricks, K Lee, E Mylonakis
Expert Opinion on Drug Discovery 12 (6), 625-633, 2017
Upoważnienia: US National Institutes of Health
Anti-MRSA agent discovery using Caenorhabditis elegans-based high-throughput screening
SM Kim, I Escorbar, K Lee, BB Fuchs, E Mylonakis, W Kim
Journal of Microbiology 58, 431-444, 2020
Upoważnienia: US National Institutes of Health
Dostępne w jakimś miejscu: 25
A new class of synthetic retinoid antibiotics effective against bacterial persisters
W Kim, W Zhu, GL Hendricks, D Van Tyne, AD Steele, CE Keohane, ...
Nature 556 (7699), 103-107, 2018
Upoważnienia: US National Science Foundation, US National Institutes of Health
Repurposing salicylanilide anthelmintic drugs to combat drug resistant Staphylococcus aureus
R Rajamuthiah, BB Fuchs, AL Conery, W Kim, E Jayamani, B Kwon, ...
PloS one 10 (4), e0124595, 2015
Upoważnienia: US National Institutes of Health
A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant Staphylococcus aureus
W Kim, G Zou, TPA Hari, IK Wilt, W Zhu, N Galle, HA Faizi, GL Hendricks, ...
Proceedings of the National Academy of Sciences 116 (33), 16529-16534, 2019
Upoważnienia: US National Science Foundation, US National Institutes of Health
Identification of an antimicrobial agent effective against methicillin-resistant Staphylococcus aureus persisters using a fluorescence-based screening strategy
W Kim, AL Conery, R Rajamuthiah, BB Fuchs, FM Ausubel, E Mylonakis
PLoS One 10 (6), e0127640, 2015
Upoważnienia: US National Institutes of Health
Synergistic efficacy of Aedes aegypti antimicrobial peptide cecropin A2 and tetracycline against Pseudomonas aeruginosa
Z Zheng, N Tharmalingam, Q Liu, E Jayamani, W Kim, BB Fuchs, R Zhang, ...
Antimicrobial agents and chemotherapy 61 (7), 10.1128/aac. 00686-17, 2017
Upoważnienia: US National Institutes of Health
Antimicrobial Activity of 1,3,4-oxadiazole Derivatives Against Planktonic Cells and Biofilm of Staphylococcus Aureus
Z Zheng, Q Liu, W Kim, N Tharmalingam, BB Fuchs, E Mylonakis
Future medicinal chemistry 10 (3), 283-296, 2018
Upoważnienia: US National Institutes of Health
Nh125 Kills Methicillin-Resistant Staphylococcus Aureus Persisters by Lipid Bilayer Disruption
W Kim, N Fricke, AL Conery, BB Fuchs, R Rajamuthiah, E Jayamani, ...
Future medicinal chemistry 8 (3), 257-269, 2016
Upoważnienia: US National Institutes of Health
Strategies against Methicillin-Resistant Staphylococcus Aureus Persisters
W Kim, GL Hendricks, K Tori, BB Fuchs, E Mylonakis
Future medicinal chemistry 10 (7), 779-794, 2018
Upoważnienia: US National Institutes of Health
A Defensin from the Model Beetle Tribolium castaneum Acts Synergistically with Telavancin and Daptomycin against Multidrug Resistant Staphylococcus aureus
R Rajamuthiah, E Jayamani, AL Conery, BB Fuchs, W Kim, T Johnston, ...
PLoS One 10 (6), e0128576, 2015
Upoważnienia: US National Institutes of Health
Discovery and optimization of nTZDpa as an antibiotic effective against bacterial persisters
W Kim, AD Steele, W Zhu, EE Csatary, N Fricke, MM Dekarske, ...
ACS infectious diseases 4 (11), 1540-1545, 2018
Upoważnienia: US National Science Foundation, US National Institutes of Health
Topical niclosamide (ATx201) reduces Staphylococcus aureus colonization and increases Shannon diversity of the skin microbiome in atopic dermatitis patients in …
A Weiss, E Delavenne, C Matias, H Lagler, D Simon, P Li, JU Hansen, ...
Clinical and Translational Medicine 12 (5), e790, 2022
Upoważnienia: Innovation Fund Denmark
The neutrally charged diarylurea compound PQ401 kills antibiotic-resistant and antibiotic-tolerant Staphylococcus aureus
W Kim, G Zou, W Pan, N Fricke, HA Faizi, SM Kim, R Khader, S Li, K Lee, ...
MBio 11 (3), 10.1128/mbio. 01140-20, 2020
Upoważnienia: US National Institutes of Health, A*Star, Singapore
Antibacterial Properties of Four Novel Hit Compounds from a Methicillin-Resistant Staphylococcus aureus–Caenorhabditis elegans High-Throughput Screen
N Tharmalingam, R Rajmuthiah, W Kim, BB Fuchs, E Jeyamani, MJ Kelso, ...
Microbial Drug Resistance 24 (5), 666-674, 2018
Upoważnienia: US National Institutes of Health
Auranofin is an Effective Agent against Clinical Isolates of Staphylococcus Aureus
N Tharmalingam, NQ Ribeiro, DL Da Silva, MT Naik, LIB Cruz, W Kim, ...
Future Medicinal Chemistry 11 (12), 1417-1425, 2019
Upoważnienia: US National Institutes of Health
Characterization of a Francisella tularensis-Caenorhabditis elegans pathosystem for the evaluation of therapeutic compounds
E Jayamani, N Tharmalingam, R Rajamuthiah, JJ Coleman, W Kim, ...
Antimicrobial agents and chemotherapy 61 (9), 10.1128/aac. 00310-17, 2017
Upoważnienia: US National Institutes of Health
Antibacterial properties of 3-(phenylsulfonyl)-2-pyrazinecarbonitrile
R Rajamuthiah, E Jayamani, H Majed, AL Conery, W Kim, B Kwon, ...
Bioorganic & medicinal chemistry letters 25 (22), 5203-5207, 2015
Upoważnienia: US National Institutes of Health
Structure–activity relationship and anticancer profile of second-generation anti-MRSA synthetic retinoids
AV Cheng, W Kim, IE Escobar, E Mylonakis, WM Wuest
ACS Medicinal Chemistry Letters 11 (3), 393-397, 2019
Upoważnienia: US National Science Foundation, US National Institutes of Health
Influence of Subinhibitory Concentrations of NH125 on Biofilm Formation & Virulence Factors of Staphylococcus Aureus
Q Liu, Z Zheng, W Kim, B Burgwyn Fuchs, E Mylonakis
Future Medicinal Chemistry 10 (11), 1319-1331, 2018
Upoważnienia: US National Institutes of Health
Informacje na temat publikacji i finansowania automatycznie określa program komputerowy